229 related articles for article (PubMed ID: 21237690)
21. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
[TBL] [Abstract][Full Text] [Related]
22. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer].
Sun HW; Chen LH; Wei CJ; Zheng XK; Li QS; Guan J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1133-6. PubMed ID: 19726341
[TBL] [Abstract][Full Text] [Related]
23. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
24. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment for hepatocellular carcinoma with main portal vein tumor thrombi by 3-dimensional conformal radiation therapy combined with transarterial chemoembolization.
Gwak GY; Yoon JH; Chie EK; Chung JW; Lee HS
Hepatogastroenterology; 2008; 55(82-83):673-6. PubMed ID: 18613431
[TBL] [Abstract][Full Text] [Related]
26. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial].
Mornex F; Girard N; Merle P; Béziat C; Kubas A; Wautot V; Khodri M; Trepo C
Cancer Radiother; 2005 Nov; 9(6-7):470-6. PubMed ID: 16219480
[TBL] [Abstract][Full Text] [Related]
27. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
Dharancy S; Boitard J; Decaens T; Sergent G; Boleslawski E; Duvoux C; Vanlemmens C; Meyer C; Gugenheim J; Durand F; Boillot O; Declerck N; Louvet A; Canva V; Romano O; Ernst O; Mathurin P; Pruvot FR
Liver Transpl; 2007 May; 13(5):665-71. PubMed ID: 17427172
[TBL] [Abstract][Full Text] [Related]
28. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS
Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160
[TBL] [Abstract][Full Text] [Related]
29. Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy.
Merle P; Mornex F; Trepo C
Cancer Lett; 2009 Dec; 286(1):129-33. PubMed ID: 19138819
[TBL] [Abstract][Full Text] [Related]
30. [Hepatocellular carcinoma: npn-surgical treatment].
Allgaier HP; Deibert P; Becker G; Blum HE
Praxis (Bern 1994); 1998 Oct; 87(44):1466-70. PubMed ID: 9847686
[TBL] [Abstract][Full Text] [Related]
31. Treatment of hepatocellular carcinoma: medical options.
Fried MW
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S92-7. PubMed ID: 9742500
[TBL] [Abstract][Full Text] [Related]
32. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
[TBL] [Abstract][Full Text] [Related]
33. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.
Chok KS; Ng KK; Poon RT; Lam CM; Yuen J; Tso WK; Fan ST
Arch Surg; 2006 Dec; 141(12):1231-6. PubMed ID: 17178966
[TBL] [Abstract][Full Text] [Related]
34. [Nonsurgical management of hepatocellular carcinoma].
Merle P; Mornex F
Cancer Radiother; 2010 Oct; 14(6-7):469-73. PubMed ID: 20739209
[TBL] [Abstract][Full Text] [Related]
35. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
36. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
Huo T; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 Jun; 19(12):1301-8. PubMed ID: 15191512
[TBL] [Abstract][Full Text] [Related]
37. Management of hepatocellular carcinoma.
Yu AS; Keeffe EB
Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
[TBL] [Abstract][Full Text] [Related]
38. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
[TBL] [Abstract][Full Text] [Related]
39. Chemoembolization and bland embolization: a critical appraisal.
Befeler AS
Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
[TBL] [Abstract][Full Text] [Related]
40. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
